Since NKG2D is also expressed on NKT cells, CD8+ T cells, γδ T cells, and some activated CD4+ T cells [57], fusion protein MICA-G129R may also attract and activate these cells to fight against breast cancer. This evidence concerns the gene CD4 and breast carcinoma.